Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Kevin Bercimuelle-Chamot, Jocelyn Bosse, Alessandro Cerri, Anastasiia Kyrylenko, Marcel Pemsel and Anna Maria Stein.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Antonios Baris (Book Review Editor), Rose Hughes (PatKat) and Chijioke Okorie (Africa Correspondent).

InternKats: Asude Sena Moya and Söğüt Atilla.
Home / copyright / internet / patents / pharmaceutical industry / New Zealand rejects ISP rule; GSK patent pool

New Zealand rejects ISP rule; GSK patent pool

- , , ,
Three strikes struck out

The Register reports that the New Zealand government has put on hold plans for a 'three strikes and you're out' rule, forcing ISPs to disconnect those accused of illegal downloading three times. This follows a concerted internet campaign against the measure - s.92a of the Copyright Act . However, s.92a is to be rewritten, and John Key, the NZ prime minister has said that he won't allow the internet to become a 'Wild West' for piracy.

The IPKat is happy about this. As more and more activities take place over the internet (in terms of communication, interactions with local and central government and of course business transactions), a complete cutting off of internet access looks particularly punitive.


Pharma patent pool

Reuters reports that GSK has placed 800 drugs into a patent pool to be shared with others trying to find cures for neglected tropical diseases. The move was announced in GSK's corporate responsibility annual report yesterday. Meanwhile the Guardian reports that International Development minister, Ivan Lewis, plans to approach leading pharmaceutical companies to encourage them to join the pool. Mr Lewis said "Challenging pharma to do their bit ... is entirely legitimate."

The IPKat welcome's GSK's move. He's not sure whether it's the job of government to go round drumming up support for the scheme and telling people how to use their private property though.
New Zealand rejects ISP rule; GSK patent pool New Zealand rejects ISP rule; GSK patent pool Reviewed by Anonymous on Wednesday, March 25, 2009 Rating: 5

1 comment:

  1. goldenrailFriday, 27 March 2009 at 14:52:00 GMT

    Wondering - after pharma makes enough moves so drugs become fairly well accessible in developing countries, will special agricultural products be the next focus point? i.e., once diseases are handled by influx of proper medication, will biotech be expected to help handle food shortages by making improved seeds available cheaply in developing countries?
    (Just thinking about this based on presentation by Monsanto yesterday in class - African countries don't use their drought-resistant seeds because too expensive.)

    ReplyDelete

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Subscribe to: Post Comments ( Atom )
Powered by Blogger.